Response

Affiliations

¹ Department of Medicine, F. Edward Hebert School of Medicine at the Uniformed Services University of the Health Sciences, Bethesda, MD. Electronic address: lisa.moores@usuhs.edu.
² Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
³ Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, ON, Canada.

Comment

Lisa K Moores et al. Chest. 2022 Jul.

. 2022 Jul;162(1):e70-e71.

doi: 10.1016/j.chest.2022.03.037.

¹ Department of Medicine, F. Edward Hebert School of Medicine at the Uniformed Services University of the Health Sciences, Bethesda, MD. Electronic address: lisa.moores@usuhs.edu.
² Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
³ Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, ON, Canada.

No abstract available

Comment on

Thromboprophylaxis in Patients With COVID-19: A Brief Update to the CHEST Guideline and Expert Panel Report.
Moores LK, Tritschler T, Brosnahan S, Carrier M, Collen JF, Doerschug K, Holley AB, Iaccarino J, Jimenez D, LeGal G, Rali P, Wells P. Moores LK, et al. Chest. 2022 Jul;162(1):213-225. doi: 10.1016/j.chest.2022.02.006. Epub 2022 Feb 12. Chest. 2022. PMID: 35167861 Free PMC article.

1. Moores L.K., Tritschler T., Brosnahan S., et al. Thromboprophylaxis in patients with COVID-2019: a brief update to the CHEST guideline and expert panel report. Chest. 2022;162(1):213–225. - PMC - PubMed
1. Lopes R.D., de Barros e Silva P.G.M., Furtado R.H.M., et al. ACTION Coalition COVID-19 Brazil IV Investigators. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial. Lancet. 2021;397(10291):2253–2263. - PMC - PubMed
1. ATTACC Investigators, ACTIV-4a Investigators, REMAP-CAP Investigators, et al. Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19. N Engl J Med. 2021;385(9):790–802. - PMC - PubMed
1. Jiménez D., García-Sanchez A., Rali P., et al. Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Chest. 2021;159(3):1182–1196. - PMC - PubMed
1. Demelo-Rodriguez P., Farfan-Sedano A.I., Pedrajas J.M., et al. Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis. J Thromb Haemost. 2021;19(8):1981–1989. - PMC - PubMed